Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1992 Feb;66(2):1267–1272. doi: 10.1128/jvi.66.2.1267-1272.1992

v-mos proteins encoded by myeloproliferative sarcoma virus and its ts159 mutant.

B Singh 1, C Stocking 1, R Walker 1, Y D Yang 1, W Ostertag 1, R B Arlinghaus 1
PMCID: PMC240840  PMID: 1309903

Abstract

The myeloproliferative sarcoma virus (MPSV) v-mos protein was predicted to be identical in size to p39c-mos because of an observed one-base deletion in the seventh codon of the env-mos open reading frame, which would allow translation to initiate at the methionine equivalent to codon 32 of the env-mos gene. On the basis of published results, p39c-mos is known to have greatly reduced in vitro protein kinase activity compared with p37env-mos encoded by Moloney murine sarcoma virus. Unexpectedly, the relative activity of the MPSV v-mos protein kinase was comparable to that of p37env-mos. Consistent with this finding, the size of MPSV v-mos protein was found to be similar to the size of p37env-mos. Moreover, the pattern and sizes of phosphorylated bands produced by autophosphorylation of the MPSV v-mos protein were similar to those of p37env-mos. These results were confirmed by in vitro transcription-translation of the MPSV v-mos gene. Resequencing portions of the MPSV mos gene failed to show the deletion within codon 7. Except for the codon 262 deletion, other mutations characteristic of MPSV and temperature-sensitive MPSV v-mos genes were confirmed. A glycine-to-arginine mutation at residue 338 of the MPSV env-mos sequence, previously shown to cause thermosensitivity of the mutant virus (termed ts159) transforming function, yielded a v-mos protein that had significantly reduced protein kinase activity in vitro. These findings indicate that MPSV, like other Moloney murine sarcoma virus strains, also encodes a functional env-mos protein.

Full text

PDF
1267

Images in this article

1268Image
on p.1268
1269Image
on p.1269
1269Image
on p.1269
1270Image
on p.1270
1270Image
on p.1270
1271Image
on p.1271

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bold R. J., Donoghue D. J. Biologically active mutants with deletions in the v-mos oncogene assayed with retroviral vectors. Mol Cell Biol. 1985 Nov;5(11):3131–3138. doi: 10.1128/mcb.5.11.3131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brow M. A., Sen A., Sutcliffe J. G. Nucleotide sequence of the transforming gene of m1 murine sarcoma virus. J Virol. 1984 Feb;49(2):579–582. doi: 10.1128/jvi.49.2.579-582.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Escobedo J., Singh B., Dina D., Arlinghaus R. B. Temperature-dependent cytocidal effects of Moloney murine sarcoma virus. Virus Res. 1986 Oct;6(1):75–84. doi: 10.1016/0168-1702(86)90058-4. [DOI] [PubMed] [Google Scholar]
  4. Freeman R. S., Donoghue D. J. Transforming mutant v-mos protein kinases that are deficient in in vitro autophosphorylation. Mol Cell Biol. 1989 Sep;9(9):4087–4090. doi: 10.1128/mcb.9.9.4087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Freeman R. S., Pickham K. M., Kanki J. P., Lee B. A., Pena S. V., Donoghue D. J. Xenopus homolog of the mos protooncogene transforms mammalian fibroblasts and induces maturation of Xenopus oocytes. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5805–5809. doi: 10.1073/pnas.86.15.5805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Friel J., Stocking C., Stacey A., Ostertag W. A temperature-sensitive mutant of the myeloproliferative sarcoma virus, altered by a point mutation in the mos oncogene, has been modified as a selectable retroviral vector. J Virol. 1987 Mar;61(3):889–897. doi: 10.1128/jvi.61.3.889-897.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gallick G. E., Sparrow J. T., Singh B., Maxwell S. A., Stanker L. H., Arlinghaus R. B. Recognition of mos-related proteins with an antiserum to a peptide of the v-mos gene product. J Gen Virol. 1985 May;66(Pt 5):945–955. doi: 10.1099/0022-1317-66-5-945. [DOI] [PubMed] [Google Scholar]
  8. Hanks S. K., Quinn A. M., Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science. 1988 Jul 1;241(4861):42–52. doi: 10.1126/science.3291115. [DOI] [PubMed] [Google Scholar]
  9. Herzog N. K., Nash M., Ramagli L. S., Arlinghaus R. B. v-mos protein produced by in vitro translation has protein kinase activity. J Virol. 1990 Jun;64(6):3093–3096. doi: 10.1128/jvi.64.6.3093-3096.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Herzog N. K., Ramagli L. S., Khorana S., Arlinghaus R. B. Evidence for somatic cell expression of the c-mos protein [corrected]. Oncogene. 1989 Nov;4(11):1307–1315. [PubMed] [Google Scholar]
  11. Herzog N. K., Singh B., Elder J., Lipkin I., Trauger R. J., Millette C. F., Goldman D. S., Wolfes H., Cooper G. M., Arlinghaus R. B. Identification of the protein product of the c-mos proto-oncogene in mouse testes. Oncogene. 1988 Aug;3(2):225–229. [PubMed] [Google Scholar]
  12. Kloetzer W. S., Maxwell S. A., Arlinghaus R. B. P85gag-mos encoded by ts110 Moloney murine sarcoma virus has an associated protein kinase activity. Proc Natl Acad Sci U S A. 1983 Jan;80(2):412–416. doi: 10.1073/pnas.80.2.412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Maxwell S. A., Arlinghaus R. B. Serine kinase activity associated with Maloney murine sarcoma virus-124-encoded p37mos. Virology. 1985 May;143(1):321–333. doi: 10.1016/0042-6822(85)90119-9. [DOI] [PubMed] [Google Scholar]
  14. Maxwell S. A., Arlinghaus R. B. Use of site-specific antipeptide antibodies to perturb the serine kinase catalytic activity of p37mos. J Virol. 1985 Sep;55(3):874–876. doi: 10.1128/jvi.55.3.874-876.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ostertag W., Stocking C., Johnson G. R., Kluge N., Kollek R., Franz T., Hess N. Transforming genes and target cells of murine spleen focus-forming viruses. Adv Cancer Res. 1987;48:193–355. doi: 10.1016/s0065-230x(08)60693-4. [DOI] [PubMed] [Google Scholar]
  16. Papkoff J., Verma I. M., Hunter T. Detection of a transforming gene product in cells transformed by Moloney murine sarcoma virus. Cell. 1982 Jun;29(2):417–426. doi: 10.1016/0092-8674(82)90158-1. [DOI] [PubMed] [Google Scholar]
  17. Paules R. S., Buccione R., Moschel R. C., Vande Woude G. F., Eppig J. J. Mouse Mos protooncogene product is present and functions during oogenesis. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5395–5399. doi: 10.1073/pnas.86.14.5395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sagata N., Oskarsson M., Copeland T., Brumbaugh J., Vande Woude G. F. Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes. Nature. 1988 Oct 6;335(6190):519–525. doi: 10.1038/335519a0. [DOI] [PubMed] [Google Scholar]
  19. Sagata N., Watanabe N., Vande Woude G. F., Ikawa Y. The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs. Nature. 1989 Nov 30;342(6249):512–518. doi: 10.1038/342512a0. [DOI] [PubMed] [Google Scholar]
  20. Schmidt M., Oskarsson M. K., Dunn J. K., Blair D. G., Hughes S., Propst F., Vande Woude G. F. Chicken homolog of the mos proto-oncogene. Mol Cell Biol. 1988 Feb;8(2):923–929. doi: 10.1128/mcb.8.2.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Seth A., Vande Woude G. F. Nucleotide sequence and biochemical activities of the Moloney murine sarcoma virus strain HT-1 mos gene. J Virol. 1985 Oct;56(1):144–152. doi: 10.1128/jvi.56.1.144-152.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Singh B., Arlinghaus R. B. Vimentin phosphorylation by p37mos protein kinase in vitro and generation of a 50-kDa cleavage product in v-mos-transformed cells. Virology. 1989 Nov;173(1):144–156. doi: 10.1016/0042-6822(89)90230-4. [DOI] [PubMed] [Google Scholar]
  23. Singh B., Goldman R., Hutton L., Herzog N. K., Arlinghaus R. B. The P55 protein affected by v-mos expression is vimentin. J Virol. 1987 Nov;61(11):3625–3629. doi: 10.1128/jvi.61.11.3625-3629.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Singh B., Hannink M., Donoghue D. J., Arlinghaus R. B. p37mos-associated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos. J Virol. 1986 Dec;60(3):1148–1152. doi: 10.1128/jvi.60.3.1148-1152.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Singh B., Wittenberg C., Hannink M., Reed S. I., Donoghue D. J., Arlinghaus R. B. The histidine-221 to tyrosine substitution in v-mos abolishes its biological function and its protein kinase activity. Virology. 1988 May;164(1):114–120. doi: 10.1016/0042-6822(88)90626-5. [DOI] [PubMed] [Google Scholar]
  26. Singh B., al-Bagdadi F., Liu J. X., Arlinghaus R. B. Use of antipeptide antibodies to probe the catalytic activity of p37v-mos. Virology. 1990 Oct;178(2):535–542. doi: 10.1016/0042-6822(90)90351-q. [DOI] [PubMed] [Google Scholar]
  27. Stacey A., Arbuthnott C., Kollek R., Coggins L., Ostertag W. Comparison of myeloproliferative sarcoma virus with Moloney murine sarcoma virus variants by nucleotide sequencing and heteroduplex analysis. J Virol. 1984 Jun;50(3):725–732. doi: 10.1128/jvi.50.3.725-732.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stocking C., Kollek R., Bergholz U., Ostertag W. Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus. Proc Natl Acad Sci U S A. 1985 Sep;82(17):5746–5750. doi: 10.1073/pnas.82.17.5746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stocking C., Kollek R., Bergholz U., Ostertag W. Point mutations in the U3 region of the long terminal repeat of Moloney murine leukemia virus determine disease specificity of the myeloproliferative sarcoma virus. Virology. 1986 Aug;153(1):145–149. doi: 10.1016/0042-6822(86)90015-2. [DOI] [PubMed] [Google Scholar]
  30. Van Beveren C., van Straaten F., Galleshaw J. A., Verma I. M. Nucleotide sequence of the genome of a murine sarcoma virus. Cell. 1981 Nov;27(1 Pt 2):97–108. doi: 10.1016/0092-8674(81)90364-0. [DOI] [PubMed] [Google Scholar]
  31. Watson R., Oskarsson M., Vande Woude G. F. Human DNA sequence homologous to the transforming gene (mos) of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A. 1982 Jul;79(13):4078–4082. doi: 10.1073/pnas.79.13.4078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Yew N., Oskarsson M., Daar I., Blair D. G., Vande Woude G. F. mos gene transforming efficiencies correlate with oocyte maturation and cytostatic factor activities. Mol Cell Biol. 1991 Feb;11(2):604–610. doi: 10.1128/mcb.11.2.604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Zhao X., Batten B., Singh B., Arlinghaus R. B. Requirement of the c-mos protein kinase for murine meiotic maturation. Oncogene. 1990 Nov;5(11):1727–1730. [PubMed] [Google Scholar]
  34. van der Hoorn F. A., Firzlaff J. Complete c-mos (rat) nucleotide sequence: presence of conserved domains in c-mos proteins. Nucleic Acids Res. 1984 Feb 24;12(4):2147–2156. doi: 10.1093/nar/12.4.2147. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES